SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-007772
Filing Date
2012-02-06
Accepted
2012-02-06 16:05:23
Documents
2
Period of Report
2012-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6790
2 POA DOCUMENT poa.txt EX-24.4_407865 3547
  Complete submission text file 0001209191-12-007772.txt   11598
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Howton David T (Reporting) CIK: 0001529297 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 12573680